SLAMF6: A New Target in Cancer Immunotherapy

Kilder

• Nature: SLAMF6 as a drug-targetable suppressor of T cell immunity against cancer - Nature
• Nature: Injury and therapy in a human spinal cord organoid - Nature
• Nature: Tiny robot fish could swim through the body powered by ultrasound - Nature
• Statnews: Prasad overruled FDA staff to reject Moderna’s flu vaccine application - statnews.com
• Statnews: Merck is urged by patient groups to ensure widespread access to an HIV prevention pill being tested - statnews.com
• Bioworld: Ascletis raises $107M to advance oral GLP-1 to phase III trials - BioWorld MedTech

Oppsummeringen og talen er laget med KI. Kildelenkene viser opphavet og er ikke en anbefaling av TellMe fra mediene.